Weight gain after stopping Eli Lilly's new obesity treatment should help, not hurt the stock

Data showing weight gain after stopping Eli Lilly's Zepbound was positive despite earlier selling pressure, Jim Cramer said Tuesday.

from Health and Science https://ift.tt/h5aXsOq
https://ift.tt/OYkr8SG
https://ift.tt/j3cOMIp